Xiangqing Kong

Publication Activity (10 Years)

Years Active: 2021-2022
Publications (10 Years): 3

Top Topics

Nlrp Inflammasome

Top Venues

Clinical and experimental pharmacology & physiology

Cardiovascular drugs and therapy

Cell death discovery

This page only lists publications with an associated author ORCID identifier.

Publications

Liqing Weng, Lu Li, Kun Zhao, Tianhua Xu, Yukang Mao, Huanyu Shu, Xuguan Chen, Ji Chen, Jian Wu, Xiasheng Guo, Juan Tu, Dong Zhang, Wei Sun, Xiangqing Kong
Non-Invasive Local Acoustic Therapy Ameliorates Diabetic Heart Fibrosis by Suppressing ACE-Mediated Oxidative Stress and Inflammation in Cardiac Fibroblasts. Cardiovascular drugs and therapy 36 (3) (2022)
Kun Zhao, Chuanxi Yang, Jing Zhang, Wei Sun, Bin Zhou, Xiangqing Kong, Jing Shi
METTL3 improves cardiomyocyte proliferation upon myocardial infarction via upregulating miR-17-3p in a DGCR8-dependent manner. Cell death discovery 7 (1) (2021)
Kun Zhao, Liqing Weng, Tianhua Xu, Chuanxi Yang, Jing Zhang, Gehui Ni, Xiasheng Guo, Juan Tu, Dong Zhang, Wei Sun, Xiangqing Kong
Low-intensity pulsed ultrasound prevents prolonged hypoxia-induced cardiac fibrosis through HIF-1α/DNMT3a pathway via a TRAAK-dependent manner. Clinical and experimental pharmacology & physiology 48 (11) (2021)